AASLD - Hepatitis Conference - Liver Conference - HCV - HepC - HBV - HepB
A Smart + Strong Site
Subscribe to:
Hep Magazine In Bulk
Hep Newsletter
Join Us:
HIGHLIGHTS
What you need to know
> Blogs > Hep Exclusives > Hepatitis News > Lessons


Interferon-Free Hep C Treatment Safe & Effective

Combo with a next-wave protease inhibitor and a non-nucleoside polymerase inhibitor does well in phase IIb.



94% Hep C Cure Rate in Hard-to-Treat Patients

Triple combination therapy shows promise in phase II study.



Hep C Therapy Shows 100% Cure Rate

Positive news from interim data of an ongoing phase II study.


Safe and Effective for
Hep B

New study shows drug is safe and effective for long-term treatment of hep B.



New Therapy for Previous Non-Responders

Combination proved both safe and effective among patients with previous treatment experience.



Interferon-Free Hep C Regimen Has Over 90% Cure Rate

Three-drug regimen reached a 97% cure rate for treatment-naive patients.


Big Changes on Horizon for Hep C Treatment

Pharmaceutical industry is poised to revolutionize care over the coming years.



Incivek Safe for Coinfection

The hepatitis C drug is effective for people with both HIV and HCV.



New Combo Boasts High Hep C Cure Rates Across Genotypes

Therapy unlikely to enter phase III because they are manufactured by different companies.

NEWSFEED
AASLD Coverage
 
Baby Boomers With Hepatitis C Drive Demand for Liver Transplants

Abbott Announces Phase III Trials of Its Potent Hep C Direct Acting Agents

Long-term Entecavir Is Safe and Effective for Hep B Patients, Even with Cirrhosis

Daclatasvir, Asunaprevir Regimens Boast High Cure Rates in Hard-to-Treat Hep C

Interferon-Free Hep C Treatment With Faldaprevir is Safe & Effective

Liver Cancer Spikes Among Spanish Coinfected With HIV, Hepatitis

Tenofovir Is Safe and Effective for Hep B, Yields Little Bone Loss

Simeprevir Is Safe and Effective for Hep C Patients With Advanced Fibrosis

Daclatasvir, Sofosbuvir Combo Boasts High Hep C Cure Rates Across Genotypes

New Hep C Combo Therapies Safe & Effective for Previous Non-Responders

BMS’s Hep C Therapy Shows 94% Cure Rate in Hard-to-Treat Patients

Hep C Protease Inhibitor Incivek Is Safe, Effective for HIV Coinfection

Gilead’s Hep C Combo Therapy Shows 100% Cure Rate in Small Study

Abbott’s Interferon-Free Hep C Regimen Boasts Over 90% Cure Rates

 
HEP TV
Footage from the front lines
Andrew Muir, MD, MHS, chief of the Duke Division of Gastroenterology, on first visiting a liver specialist.
> More Hep TV
TALK TO US
Tell us what you think
Poll
Have you gotten headaches while on hep C treatment?
Yes
No


Survey
Hepatitis C Reader Survey
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.